|
2025
|
Invention
|
Composition for inhibiting accumulation of α-synuclein, and use therefor. One embodiment of the p... |
|
2024
|
Invention
|
Method for modulating activity of crispr/cas, and use thereof. Provided is a method for rapidly c... |
|
|
Invention
|
Method for inducing cellular immunity through nasal administration. The present disclosure provid... |
|
|
Invention
|
Mhc gene cluster–deficient animal. The present invention provides a production method for cells t... |
|
|
Invention
|
Antibody or functional fragment thereof, and use thereof. Provided is a tool or the like for reco... |
|
|
Invention
|
Pluripotent stem cell having doubled chromosome. 1211222 represents an integer of 2 to 16) plurip... |
|
|
Invention
|
Medication for influenza.
A medication for preventing or treating influenza, said medication inc... |
|
|
Invention
|
Nucleic acid construct coding for insulin receptor fragment and use thereof. Provided are a novel... |
|
|
Invention
|
Pharmaceutical composition for treating brain injuries. Provided is a medicine and the like which... |
|
2023
|
Invention
|
Hepatitis b vaccine composition for nasal administration and nasal administration system thereof.... |
|
|
Invention
|
Liver disease noninvasive biomarker and method for detecting liver disease using same. The presen... |
|
|
Invention
|
Method for evaluating lymph node metastasis capability of endometrial cancer. The purpose of the ... |
|
|
Invention
|
Variant neurodegenerative disease-associated protein.
A variant neurodegenerative disease-associ... |
|
|
Invention
|
Variant neurodegenerative disease-associated protein. This variant neurodegenerative disease-asso... |
|
|
Invention
|
Mhc gene group humanized animal.
A vector set including a combination of the following vectors (... |
|
|
Invention
|
Mhc gene group humanized animal. A vector set including a combination of the following vectors (A... |
|
|
Invention
|
Anti-ubiquitin synthetic antibody.
A synthetic anti-ubiquitin antibody, comprising a fibronectin... |
|
|
Invention
|
Anti-ubiquitin synthetic antibody. The present invention is an anti-ubiquitin synthetic antibody ... |
|
2022
|
Invention
|
Therapeutic agent for refractory viral infections.
The present invention provides a therapeutic ... |
|
|
Invention
|
Therapeutic agent for refractory viral infections. Provided is a therapeutic agent or the like th... |
|
|
Invention
|
Neurodegenerative and amyotrophic model animal.
Provided are: a neurodegenerative model animal a... |
|
|
Invention
|
Neurodegenerative and amyotrophic model animal. Provided are: a neurodegenerative model animal al... |
|
|
Invention
|
Transgenic non-human animal with attenuated proteasome function. Provided is a transgenic non-hum... |
|
|
Invention
|
Composition for preventing or treating cerebrovascular disease.
Provided is a composition for pr... |
|
|
Invention
|
Composition for preventing or treating cerebrovascular accident. Provided is a composition that i... |
|
2021
|
G/S
|
Educational and instruction services relating to arts,
crafts, sports or general knowledge; arra... |
|
|
Invention
|
Disease susceptibility assessment method. Provides is a method for assessing disease susceptibili... |
|
|
Invention
|
Recombinant vaccinia virus. Provided are a recombinant vaccinia virus, which is a clinically usab... |
|
|
Invention
|
Hepatitis a virus replication inhibitor targeting mtor.
[Problem to be solved] To provide a phar... |
|
2020
|
Invention
|
Transgenic non-human animal capable of controlling expression of transcription factor rp58.
Prov... |
|
|
Invention
|
Transgenic non-human animal capable of controlling expression of transcription factor rp58. Provi... |
|
|
Invention
|
Dengue virus vaccine. The present invention provides a recombinant Vaccinia virus as a dengue vir... |
|
|
Invention
|
Nucleic acid construct encoding trk fragment and use thereof.
The present invention provides: a ... |
|
|
Invention
|
Nucleic acid construct encoding trk fragment and use thereof. Provided are a novel nucleic acid c... |
|
|
Invention
|
Method of producing a novel animal model for tauopathies. The present invention provides a diseas... |
|
2019
|
Invention
|
Composition for inhibiting replication of hepatitis b virus. The present invention provides a pha... |
|
|
Invention
|
Strain dis-derived recombinant vaccinia virus having novel influenza virus-derived hemagglutinin ... |
|
|
Invention
|
Composition for inhibiting replication of hepatitis b virus. Provided is a medicinal composition ... |
|
|
Invention
|
Stabilization of double-stranded rna by cationic artificial oligosaccharide. Provided is a method... |
|
|
Invention
|
Antitumor agent targeting hgf-regulated tyrosine kinase substrate (hgs). The present invention ai... |
|
|
Invention
|
Antitumor agent targeting hgf-regulated tyrosine kinase substrate (hgs). The purpose of the prese... |
|
|
Invention
|
Hemagglutinin-binding peptide. (iv) an amino acid sequence having 90% or more sequence identity t... |
|
2018
|
Invention
|
Therapeutic agent for mental retardation or autism. A novel therapeutic agent effective for the t... |
|
|
Invention
|
Nasal hepatitis b vaccine composition and method for producing same. The present invention relate... |
|
|
Invention
|
Hepatitis b vaccine.
A hepatitis B vaccine comprising a surface antigen particle that has only h... |
|
|
Invention
|
Stable production of virulent enterovirus 71 and use thereof. Provided is a host cell for stably ... |
|
|
Invention
|
Urokinase-type plasminogen activator transgenic mouse. (iv) crossing the chimeric mice obtained i... |
|
2017
|
Invention
|
Electrodes for electroporation. An electrode for electroporation comprising a plurality of electr... |
